Literature DB >> 21953887

Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.

Michel Crépin1, Marie-Claire Dieu, Sophie Lejeune, Fabienne Escande, Denis Boidin, Nicole Porchet, Gilles Morin, Sylvie Manouvrier, Michèle Mathieu, Marie-Pierre Buisine.   

Abstract

Constitutional epimutations of DNA mismatch repair (MMR) genes have been recently reported as a possible cause of Lynch syndrome. However, little is known about their prevalence, the risk of transmission through the germline and the risk for carriers to develop cancers. In this study, we evaluated the contribution of constitutional epimutations of MMR genes in Lynch syndrome. A cohort of 134 unrelated Lynch syndrome-suspected patients without MMR germline mutation was screened for constitutional epimutations of MLH1 and MSH2 by quantitative bisulfite pyrosequencing. Patients were also screened for the presence of EPCAM deletions, a possible cause of MSH2 methylation. Tumors from patients with constitutional epimutations were extensively analyzed. We identified a constitutional MLH1 epimutation in two proband patients. For one of them, we report for the first time evidence of transmission to two children who also developed early colonic tumors, indicating that constitutional MLH1 epimutations are associated to a real risk of transgenerational inheritance of cancer susceptibility. Moreover, a somatic BRAF mutation was detected in one affected child, indicating that tumors from patients carrying constitutional MLH1 epimutation can mimic MSI-high sporadic tumors. These findings may have important implications for future diagnostic strategies and genetic counseling.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953887     DOI: 10.1002/humu.21617

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

1.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

Review 2.  Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

3.  Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.

Authors:  M P Farrell; D J Hughes; M Drost; A J Wallace; R J Cummins; T A Fletcher; M A Meany; E W Kay; N de Wind; D G Power; E J Andrews; A J Green; D J Gallagher
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

Review 4.  Epigenetic medicine and fetal alcohol spectrum disorders.

Authors:  Marisol Resendiz; Yuanyuan Chen; Nail C Oztürk; Feng C Zhou
Journal:  Epigenomics       Date:  2013-02       Impact factor: 4.778

5.  MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.

Authors:  Francesca Crucianelli; Rossella Tricarico; Daniela Turchetti; Greta Gorelli; Francesca Gensini; Roberta Sestini; Laura Giunti; Monica Pedroni; Maurizio Ponz de Leon; Serenella Civitelli; Maurizio Genuardi
Journal:  Epigenetics       Date:  2014-10       Impact factor: 4.528

6.  MLH1 methylation screening is effective in identifying epimutation carriers.

Authors:  Marta Pineda; Pilar Mur; María Dolores Iniesta; Ester Borràs; Olga Campos; Gardenia Vargas; Sílvia Iglesias; Anna Fernández; Stephen B Gruber; Conxi Lázaro; Joan Brunet; Matilde Navarro; Ignacio Blanco; Gabriel Capellá
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

7.  Differentiating Lynch-like from Lynch syndrome.

Authors:  John M Carethers
Journal:  Gastroenterology       Date:  2014-01-24       Impact factor: 22.682

8.  MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.

Authors:  Caroline Kientz; Fabienne Prieur; Alix Clemenson; Marie-Odile Joly; Marie-Laure Stachowicz; Jessie Auclair; Valéry Attignon; Renaud Schiappa; Qing Wang
Journal:  Fam Cancer       Date:  2019-11-19       Impact factor: 2.375

Review 9.  Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

Authors:  John M Carethers; Elena M Stoffel
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 10.  The role of epigenetics in Lynch syndrome.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.